Autopsy report · NCT00390247

Thalidomide for the Treatment of Malnutrition Inflammation Syndrome in Peritoneal Dialysis Patients

“Fail of applying funding”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

Chinese University of Hong Kong

Sponsor type

University, hospital or other

Conditions

Peritoneal Dialysis; Malnutrition

Interventions

thalidomide

Participants

0

Sites

1

Countries

Hong Kong

Trials that died the same way

• Biomarkers for Bipolar Disorder: Chaperones and Reticulum Endoplasmatic Stress Response CHAP´s Study
  “fail to get funding” (88% match in meaning)
• Intense Regulated Pulsed Light Vs Standard of Care for the Treatment of Meibomian Gland Dysfunction
  “Failed to gain funding” (84% match in meaning)
• Complementary/Integrative Medicine for Brain Cancer Patients
  “Unable to attain funding” (80% match in meaning)
• Improving Fibrosis Outcomes With Metformin
  “insufficient funding” (75% match in meaning)
• Scribes in the Emergency Department
  “Funding not received” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.